Fundamental Research Division
The DRF at the CEA assemble approximately 6,000 scientists since January 2016.
News | Newsletter | CEA Research News | European ＆ international partnerships | Health ＆ life sciences | Diagnosis and innovative treatment | Pharmacology | Structural biology | High-throughput screening
Based on the study of two hundred poisonous animals, the European project VENOMICS managed to reproduce a bank of 3,616 “natural” toxins compatible with high throughput screening. As many as 280 active substances against diseases such as diabetes, obesity, inflammation and allergies were identified. VENOMICS demonstrated that animal toxins are hundred times more effective in identifying drug candidates than the usual banks of artificial molecules. R&D activities focusing on new therapeutic molecules have already started at CEA and in pharmaceutical laboratories.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.